Here's how you can reach us...
  • Tel:
  • Email:

Gene Therapy Formulation Sterility Testing

Inquiry

In recent years, with the rapid development of gene therapy products, the development of gene therapy formulations has gradually become a hotspot in the world of science and research in various of research fields, including oncology. However, gene therapy formulations are different from traditional sterile pharmaceuticals in that they have the special characteristics of large process variability, small production volume, short potency period, and urgent clinical needs, and therefore need to be subjected to rapid aseptic testing of the products. CD Formulation has rich experience in the development of gene therapy formulations, and we have an advanced and comprehensive technology platform for the development of gene therapy formulations. Our research team provides reliable sterility testing support for the quality control of gene therapy formulations.

The Importance of Gene Therapy Formulation Sterility Testing

The production process of gene therapy formulations is complex and susceptible to a variety of factors, and their components are complicated and generally cannot be terminally sterilized. Therefore, strict quality control of gene therapy preparations is a necessary measure to reduce the risk of contamination by exogenous factors or toxic impurities in the products and to ensure their safety and effectiveness.

  • Ensuring safety. Gene therapy products are often used to treat serious hereditary diseases, and the presence of microbial contamination in the products may lead to patient infections with serious or even fatal consequences. Sterility testing is a critical step in ensuring product safety.
  • Improve product quality. Sterility testing is an important part of gene therapy product quality control, through which contamination problems during the production process can be detected promptly so that measures can be taken to improve the production process and product quality.
  • Prepare for commercialization. In the process of commercialization of gene therapy preparations, the results of sterility testing serve as an important basis for the release of the product, which is a key factor for whether the product can enter the market.

Explore Our Gene Therapy Formulation Rapid Sterility Testing

With the rapid development of biotherapeutic products, traditional sterility testing methods are no longer able to meet the current requirements for speed and efficiency. Therefore, we address this issue by providing rapid sterility testing technical support to provide faster and more reliable test results to ensure product safety and quality. Our rapid sterility testing technologies are based on microbial growth information, direct determination of live microorganisms, and analysis of specific components of microbial cells. These technologies include but are not limited to, bioluminescence, electrochemistry, and flow cytometry. We can provide results in a relatively short period while maintaining high sensitivity and accuracy.

We can provide the following rapid sterile assays.

Customized testing solutions

Design personalized sterility testing solutions according to the characteristics and needs of the customer's products.

Methodology validation

Provide methodology validation services in compliance with regulations to ensure the validity and compliance of testing methods.

Testing platform construction

Establish a high-standard testing service platform to provide services including biosafety testing, methodology development, target validation, and evaluation.

Data analysis and reporting

Provide detailed assay reports, including data analysis, result interpretation and recommendations.

Our Service Support for Gene Therapy Formulation Sterility Testing

Sample testing services

  • Sterility testing by direct inoculation method.
  • Sterility testing by membrane filtration.
  • Fungal and bacterial detection by qPCR.

Sample suitability verification services

  • Sample suitability verification by direct inoculation.
  • Sample suitability verification by membrane filtration.

Method validation service for qPCR method for fungal bacterial detection

  • Proprietary
  • Ruggedness
  • Comparability

Highlights of Our Gene Therapy Formulation Sterility Testing

  • High service efficiency. We offer rapid tests that dramatically shorten the testing cycle, helping researchers accelerate the development of gene therapy formulations and progress to market.
  • High accuracy. Our state-of-the-art technology platforms are highly sensitive and accurate, enabling researchers to complete accurate and reliable assays.
  • Cost-effective. Partnering with us can help you improve experimental efficiency and minimize unnecessary production delays, helping to reduce the overall cost of your project.
  • Experienced service. We have many years of experience in gene therapy formulation sterility testing to ensure that we can provide you with high-quality and reliable technical services.

Published Data

Technology: Sterility testing

Journal: J Clin Microbiol

IF: 5.8

Published: 2021

Current sterility testing methods, including USP<71> and blood culture systems, have limitations in detecting fungal contaminants. This study evaluated the iLYM medium, originally used in the food industry, for potential application in ATMP sterility testing. Researchers compared multiple test systems, media formulations, and incubation conditions using fungi from cleanroom environments. Results showed that traditional methods like USP<71> outperformed automated systems, but a dual-bottle combination of iLYM and iFA Plus provided fungal sensitivity comparable to USP<71>, offering a more effective testing approach for both bacterial and fungal contamination.

CD Formulation provides sterility testing services that are critical to ensuring the safety and quality of gene therapy formulations. We can provide customized testing solutions based on the needs of our clients' projects to ensure that we can help them accelerate the development process of their gene therapy formulations. If you are interested in us, please feel free to contact us.

References

  1. Putnam NE, et al. Comprehensive Study Identifies a Sensitive, Low-Risk, Closed-System Model for Detection of Fungal Contaminants in Cell and Gene Therapy Products. J Clin Microbiol. 2021, 59(11):e0135721.

CD Formulation is a leading biotechnology company focused on developing gene therapy formulations. With a strong focus on innovation and scientific excellence...

Learn More

  • Tel:
  • Email:

Stay up to date with our latest releases of new research and promotions.

Copyright © CD Formulation. All Rights Reserved.